Schedule 13D ownership disclosure

GALERA THERAPEUTICS INC

Security class unavailable · CUSIP: 36338D108

Event date: 2022-11-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,083,712
Percent of class
10.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-010750
Form type
SC 13D/A
Filer
Galera Therapeutics, Inc.
CIK
CIK 1563577
Filed
Feb 06, 2023
Reporting period
Nov 09, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub